BPA Call HHSN263201000162B-75N91024F00001
Award Date 11/29/23
Potential Completion Date 11/28/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fairfax, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $47,575.30 firm fixed price purchase order to Immudex USA, LLC for custom T-cell receptor reagents. Per the original solicitation, Immudex will provide design of relevant TCR constructs, protein expression, quality control, and final production of these reagents. The reagents will support identification and enumeration of antigen presenting...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $18,520 purchase order to Irepertoire Inc. to provide T cell samples in order to characterize T cell receptors in helper and cytotoxic T cells. This analysis will allow for the sequencing of millions of T cell receptors and identification of possible structural differences between helper and cytotoxic T cells. Irepertoire will deliver the requested T...
- The National Cancer Institute awarded a $23,853.40 firm fixed-price call under a Blanket Purchase Agreement (BPA) to 10X Genomics, Inc. on May 9, 2024, with completion scheduled for May 8, 2025. The contract procures reagents necessary to support ongoing research into T cell responses to chronic viral infections and cancer. 10X Genomics, a biotechnology company headquartered in Pleasanton, California, specializes in advanced genomic analysis platforms and reagents, including single-cell and...
- This federal contract award is a Blanket Purchase Agreement (BPA) call order placed by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Immudex USA, LLC, a foreign-owned, for-profit company specializing in advanced biological research reagents. The $3,772.00 firm fixed-price contract is for the procurement of 150 tests of a product with the description "JA3805 H-2 DB...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $20,116 firm fixed price blanket purchase agreement call contract to 10X Genomics, Inc. for biological kits. 10X Genomics will deliver the requested biological kits to support the NIH NCI's research efforts under this one month contract based in Pleasanton, California. As a leading developer of single-cell solutions, 10X Genomics is well positioned to provide these products to further...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded Roche Diagnostics Corporation a $20,463.87 firm fixed price delivery order for reagents and consumables. The contract has no set-aside designation and runs through January 13, 2023. As the largest biomedical research agency in the world, the National Cancer Institute works with both public and private partners to better understand, diagnose, and treat cancer. This delivery order...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,382.50 firm fixed price purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The order is for ELISPOT KITS to be delivered between August 21, 2023 and September 20, 2023. The National Cancer Institute conducts and supports research into the causes, prevention, diagnosis, and treatment of cancer through its various programs and divisions. No set aside...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $228,009.60 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract is for reagents and consumables to support the NCI's research efforts. No subcontractors or set aside designations were identified. The one year contract begins on September 7, 2023 and concludes on September 6, 2024. The award utilizes Illumina's products and...
- This federal contract award from the Department of Health and Human Services' National Institutes of Health's National Cancer Institute is for laboratory supplies with a potential value of fourteen thousand four hundred seventy-eight dollars and fifty-two cents ($14,478.52). Life Technologies Corporation of Billerica, Massachusetts has been awarded a firm fixed price call against a blanket purchase agreement to deliver the requested lab supplies by January 31, 2024 in support of the National...
- The National Cancer Institute (NCI) awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to 10X Genomics, Inc., a biotechnology company headquartered in Pleasanton, California, for reagents and consumables. The contract was executed on August 31, 2023, with a ceiling value of $22,259 and an ultimate completion date of September 6, 2023. No set-aside designation was applied to this award. 10X Genomics specializes in advanced genomic analysis platforms and reagents for single-cell...